Showing results (321-330 of 484) with videos related to
Sort By:
Pageof 49
Diabetes|October 27, 2001
Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural inputS M Sherck, M Shiota, J Saccomando, et al.JCO Precision Oncology|January 7, 2022
Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of <i>KRAS</i>-Mutated Non-Small-Cell Lung CancerSukhmani K Padda, Jacqueline V Aredo, Shireen Vali, et al.JAMA Surgery|May 5, 2021
Diversification of Academic Surgery, Its Leadership, and the Importance of IntersectionalityAndrea N Riner, Kelly M Herremans, Daniel W Neal, et al.Diabetes|September 17, 2009
Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivoDale S Edgerton, Christopher J Ramnanan, Carrie A Grueter, et al.Journal of Endourology|October 14, 2016
Comparison of the Nanopulse Lithotripter to the Holmium Laser: Stone Fragmentation Efficiency and Impact on Flexible Ureteroscope Deflection and FlowAdam G Kaplan, Tony T Chen, Georgy Sankin, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2024
Choosing to End African American Health Disparities in Patients With Systemic Lupus ErythematosusMatthew H Liang, Edward R Lew, Patricia A Fraser, et al.Diabetes|March 29, 2005
Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogsDale S Edgerton, Doss W Neal, Melanie Scott, et al.JTO Clinical and Research Reports|November 19, 2025
Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and OutcomesSurbhi Singhal, Caressa Hui, Joel W Neal, et al.JTO Clinical and Research Reports|May 21, 2026
Corrigendum to 'Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System-Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes' [JTO Clinical and Research Reports 6 (2025) 100914]Surbhi Singhal, Caressa Hui, Joel W Neal, et al.Lung Cancer (Amsterdam, Netherlands)|April 19, 2023
Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparisonSai-Hong I Ou, Huamao M Lin, Jin-Liern Hong, et al.Pageof 49